Drug Index
CTEXLI
Generic: CHENODIOL
Review priority: PRIORITY Marketing status: Prescription
- Route: ORAL
- Class: General Medications
- Safety profile: routine
- Latest regulatory update: 21 Feb 2025, 12:00 am (UTC)
Structured Monograph
Approval overview CTEXLI is listed in Drugs@FDA under application 219488 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient CHENODIOL Form and strength TABLET;ORAL - 250MG Sponsor MIRUM Submission history Latest submission status date: 2025-02-21 00:00:00. Submission type: ORIG.